Nonalcoholic Steatohepatitis Completed Phase 2 Trials for Pioglitazone (DB01132)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00013598Treatment of Nonalcoholic Steatohepatitis With PioglitazoneTreatment